» Articles » PMID: 31683881

Impaired Glucose Metabolism in People with Extremely Elevated High-Density Lipoprotein Cholesterol and Low Alcohol Consumption: Results of the Kanagawa Investigation of Total Checkup Data from the National Database-3 (KITCHEN-3)

Overview
Journal J Clin Med
Specialty General Medicine
Date 2019 Nov 6
PMID 31683881
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Recently, we have shown that extremely high high-density lipoprotein cholesterol (HDL-C), which was observed mostly in heavy drinkers, was associated with the incidence of diabetes. However, the observed association was influenced by the consumption of alcohol. Furthermore, it is unknown whether impaired glucose metabolism exists in people with extremely high HDL-C, regardless of their alcohol consumption. Therefore, we addressed this issue in people who did not have a habit of drinking alcohol.

Methods: In this community-based cross-sectional study, we included 177,034 participants (40-74 years old) who reported being nondrinkers. We investigated levels of HbA, fasting plasma glucose (FPG), HDL-C, and clinical parameters according to 11 levels of HDL-C concentration from 20 to 120 mg/dL or over.

Results: A total of 6112 participants with HDL-C ≥ 100 mg/dL (3.5%) showed a better lipid profile, higher prevalence amongst women, more habitual exercise, a lower prevalence of smoking, and lower body mass index (BMI). Compared with an HDL-C of 70-79 mg/dL, HDL-C ≤ 69 mg/dL (except an HDL-C of 20-29 mg/dL) and HDL-C ≥ 90 mg/dL were significantly associated with a high HbA of ≥6.0%, independently of confounding factors. This finding was distinctly demonstrated in women. Similar trends were observed when high HbA was replaced with high FPG (≥110 mg/dL).

Conclusions: Our study demonstrated that impaired glucose metabolism may exist in people with extremely high HDL-C and who hardly drink alcohol.

Citing Articles

Association Between High-Density Lipoprotein Cholesterol and Length of Hospital Stay in Acute Pancreatitis: A Retrospective Cohort Study.

Qiu L, Xu F, Dong B Int J Gen Med. 2025; 17:6545-6556.

PMID: 39759892 PMC: 11697649. DOI: 10.2147/IJGM.S487993.


Association between extremely high high-density lipoprotein-cholesterol and hypertensive retinopathy: results of a cross-sectional study from Kanagawa Investigation of Total Checkup Data from the National Database-6 (KITCHEN-6).

Nakajima K, Higuchi R, Mizusawa K, Nakamura T BMJ Open. 2021; 11(5):e043677.

PMID: 33980518 PMC: 8118016. DOI: 10.1136/bmjopen-2020-043677.

References
1.
. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002; 106(25):3143-421. View

2.
Barter P . High density lipoprotein: a therapeutic target in type 2 diabetes. Endocrinol Metab (Seoul). 2014; 28(3):169-77. PMC: 3811694. DOI: 10.3803/EnM.2013.28.3.169. View

3.
Nakajima K, Iwane T, Higuchi R, Shibata M, Takada K, Uda J . Kanagawa Investigation of the Total Check-up Data from the National database (KITCHEN): protocol for data-driven population-based repeated cross-sectional and 6-year cohort studies. BMJ Open. 2019; 9(2):e023323. PMC: 6398776. DOI: 10.1136/bmjopen-2018-023323. View

4.
Chang T, Streja E, Moradi H . Could high-density lipoprotein cholesterol predict increased cardiovascular risk?. Curr Opin Endocrinol Diabetes Obes. 2017; 24(2):140-147. DOI: 10.1097/MED.0000000000000318. View

5.
Bosanska L, Petrak O, Zelinka T, Mraz M, Widimsky Jr J, Haluzik M . The effect of pheochromocytoma treatment on subclinical inflammation and endocrine function of adipose tissue. Physiol Res. 2008; 58(3):319-325. DOI: 10.33549/physiolres.931483. View